Keywords: Hospira, Javelin, Durect, Loan, M&D, License, Posidur, Bupivacine

Hospira to fund Javelin with $2 million loan, pending outcome of merger deal; signs deal with Durect

Article | 08 June 2010

Print This

Javelin Pharmaceuticals, which last week initiated legal action to enforce a merger and loan agreement with fellow USA-based Hospira (The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in